Vanda Pharmaceuticals Inc (VNDA)
4.94
+0.04
(+0.82%)
USD |
NASDAQ |
Nov 21, 16:00
4.935
0.00 (0.00%)
Pre-Market: 20:00
Vanda Pharmaceuticals Total Liabilities (Quarterly): 103.89M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 103.89M |
| June 30, 2024 | 108.86M |
| March 31, 2024 | 108.69M |
| December 31, 2023 | 103.53M |
| September 30, 2023 | 98.50M |
| June 30, 2023 | 101.78M |
| March 31, 2023 | 108.79M |
| December 31, 2022 | 107.05M |
| September 30, 2022 | 106.13M |
| June 30, 2022 | 100.55M |
| March 31, 2022 | 101.44M |
| December 31, 2021 | 88.86M |
| September 30, 2021 | 86.45M |
| June 30, 2021 | 86.42M |
| March 31, 2021 | 75.56M |
| December 31, 2020 | 80.19M |
| September 30, 2020 | 75.33M |
| June 30, 2020 | 75.05M |
| March 31, 2020 | 72.14M |
| December 31, 2019 | 72.80M |
| September 30, 2019 | 73.54M |
| June 30, 2019 | 75.79M |
| March 31, 2019 | 72.76M |
| December 31, 2018 | 56.71M |
| September 30, 2018 | 50.52M |
| Date | Value |
|---|---|
| June 30, 2018 | 51.66M |
| March 31, 2018 | 76.17M |
| December 31, 2017 | 74.04M |
| September 30, 2017 | 75.24M |
| June 30, 2017 | 79.25M |
| March 31, 2017 | 76.58M |
| December 31, 2016 | 79.04M |
| September 30, 2016 | 79.28M |
| June 30, 2016 | 80.42M |
| March 31, 2016 | 83.73M |
| December 31, 2015 | 80.02M |
| September 30, 2015 | 74.61M |
| June 30, 2015 | 73.95M |
| March 31, 2015 | 61.17M |
| December 31, 2014 | 10.89M |
| September 30, 2014 | 78.11M |
| June 30, 2014 | 85.29M |
| March 31, 2014 | 100.00M |
| December 31, 2013 | 99.22M |
| September 30, 2013 | 105.09M |
| June 30, 2013 | 111.93M |
| March 31, 2013 | 118.66M |
| December 31, 2012 | 125.54M |
| September 30, 2012 | 134.46M |
| June 30, 2012 | 140.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
72.14M
Minimum
Mar 2020
108.86M
Maximum
Jun 2024
93.10M
Average
99.53M
Median
Total Liabilities (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 121.78M |
| Black Diamond Therapeutics Inc | 40.47M |
| Edgewise Therapeutics Inc | 22.40M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 645.12M |
| Shareholders Equity (Quarterly) | 541.22M |
| Current Ratio | 4.853 |